Heterozygous hypobetalipoproteinemia is characterized by reduced plasma concentrations of LDL cholesterol, total triglycerides, and apo B to < 50% of normal values. The molecular basis of this disorder remains unknown. The phenotype cosegregates with a DNA haplotype of the apo B gene in an Idaho pedigree, with a maximum decimal logarithm of the ratio (LOD) score of 7.56 at a recombination rate of zero. Individuals carrying this haplotype had total cholesterol levels of 96 mg/dL LDL cholesterol levels of 37 mg/dl, triglycerides levels of 51 mg/dl, and apo B levels of 38 mg/dl. This study strongly suggests that apo B mutations underlie hypobetalipoproteinemia, and demonstrates the power of the candidate gene approach in linkage analysis for unraveling genetic determinants in metabolic disorders of undefined etiology.
Introduction
Two inherited lipoprotein deficiency states, abetalipoproteinemia and hypobetalipoproteinemia (HBLP),' share similarclinical and biological features in the homozygous form (1) . Affected individuals suffer from fat malabsorption, ataxic neuropathy, atypical retinitis pigmentosa, and acanthocytosis. Chylomicrons, VLDL, and LDL are absent from plasma, and apo B, an obligatory constituent of these three lipid fractions, is not detectable immunologically. Only traces of triglycerides can be identified; cholesterol, essentially confined to the high density lipoprotein (HDL) fraction, typically has a concentration < 50 mg/dl.
The distinction between these two clinical entities rests on the blood lipid profiles of parents, both of whom are obligate heterozygotes and free of clinical manifestations (1) . Whereas parents of abetalipoproteinemia patients cannot be distinguished from normal subjects, parents ofhypobetalipoproteinemia patients usually have low concentrations of VLDL and LDL, and therefore low plasma concentrations of triglycerides and cholesterol, the latter best noted in the LDL fraction. No particular abnormality of the lipid particles or of their constituents has been identified for any lipid fraction (1) . Investigations of LDL metabolism in such subjects have shown reduced synthesis and normal catabolic rates (2, 3) . The molecular basis of this disorder is unknown; any alteration of apo B, lipoprotein assembly, and secretion could account for the clinical and biological manifestations.
Apo B is the major protein constituent of the LDL particle and the ligand for the LDL receptor that clears these particles from the circulation. Recently cDNA and genomic clones of the apo B genes have been isolated in several laboratories (4) (5) (6) (7) (8) . Screening of random individuals with various restriction enzymes (9, 10) Southern blot analysis. Two cloned segments of the apo B gene, pB8 and pB23, were prepared as described elsewhere (13) . The whole plasmids were labeled to a high specific activity (14) . From each pedigree member, 5 ,gg of DNA, prepared as described previously (15) , was digested with a 5-to 10-fold excess of restriction endonucleases Xba I, Eco RI, and MWp I (Boehringer Mannheim Biochemicals), electrophoresed in 0.7% agarose gels, and transferred to nylon membranes in a basic transfer buffer (16) . Membranes blotted with Eco RI-or Msp I-digested DNA were hybridized with 32P-labeled pB8, and membranes blotted with Xba I-4igested DNA were hybridized with 32P-labeled pB23. The restriction fragment length polymorphisms (RFLPs) in the apo B gene that can be detected in this manner have been described (9, 13) . Prehybridization and hybridization were performed using the solutions and conditions described'in reference 17.
Segregation and linkage analysis. The familial distribution oflipid measurements and apo B genotypes were analyzed with the PAP (18) and LINKAGE (19) Analysis ofthe proband's nuclearfamily. In the family tree shown in Fig. 1 , the proband is subject 34, her spouse is subject 33, and her 7 children are subjects 46-52. As reported in Table  I , the HBLP phenotype segregated in this family; the proband and three of seven offspring had LDL cholesterol levels ranging between 19 and 36 mg/dl, whereas her spouse and the other four offspring had LDL cholesterol levels ranging from 101 to 1 19 mg/dl. Southern blot analysis revealed that all four HBLP subjects shared an apo B haplotype not found in their normal relatives. Within this nuclear family, linkage was suggested by a LOD score of 1.8 at a recombination rate of zero.
Analysis ofthe extended pedigree. The proband's mother, subject 10, did not carry the apo B haplotype that segregated with HBLP in this family. The mutant allele therefore was inherited through the dead father, subject 9. His having had 11 siblings, however, offered the opportunity to detect the'occurrence of HBLP in his relatives. The pedigree of Fig. 1 summarizes the branches that were ascertained as described in Methods.
Lipid, apo B, and DNA pplymorphism determinations are reported in Table I . For the analysis, cholesterol and apo B measurements were adjusted for age and sex through regression parameters defined in previous studies (21) . Because the distribution of triglyceride levels is highly skewed, a logarithmic transformation was applied before the analysis. Simultaneous segregation and linkage analysis, as described in Methods, were performed for each of the four available quantitative measurements. A metabolic disturbance affecting the lipoprotein fraction that contains apo B as a major constituent is likely to alter all four measurements. Three of them, total cholesterol, total triglycerides, and LDL cholesterol, were measured on all sampled subjects. As each parameter involves a measurement error, using them jointly as indicators of the underlying disturbance may increase the power to establish linkage between HBLP and the apo B gene. Results of joint analyses are reported in Table II. Each of the measurements, except for triglycerides, supported with a LOD score > 3 the hypothesis that the apo B DNA marker segregates with HBLP in this pedigree (Table II) . The greatest support is obtained when all three lipid measurements were analyzed jointly; a LOD score of 7.56 for a recombination fraction of zero was then obtained. The odds of this observation arising by chance alone are < l0-'. 3 2  3 3  3 3  3 2  3 2  4 2  3 3  3 3  3 3  3 3  3 3  3 3  3 2  3 2  3 3  3 3  3 2  3 2  3 3  3 2  3 3  3 3   1 2  1 2  NA  2 2  2 2  2 2  2 2  2 To summarize the segregation and linkage evidence in a simple and descriptive manner, the estimated means and variance-covariances of the three lipid measurements were used to create a linear combination within each genotypic class. This procedure led to the definition of a compound variable for each individual assayed in the pedigree. For ease of presentation, all measurements were centered to the midpoint of the interval defined by the expected means of this compound in each genotypic class. Again, for descriptive purposes only, individuals could then be classified as HBLP or normal subjects, depending on whether they had or had not inherited the apo B haplotype that segregates with HBLP. The linkage evidence thus can be described approximately as reflected in Fig. 1 . The expected distribution and the observed values for this linear combination are reported in Fig. 2 . Note that although the cosegregation of HBLP and the apo B marker is clearly apparent, a few individuals seem not to have inherited HBLP jointly with the apo B marker. This indicates that unambiguous identification of heterozygotes cannot be achieved on the basis of these measurements alone. Analyzing the quantitative values rather than making a dichotomic classification before the analysis circumvented the issue of genotypic identification. 
